ERS International Congress, Paris 2018

Browse by day: Saturday, 15.09.2018 Sunday, 16.09.2018 Monday, 17.09.2018 Tuesday, 18.09.2018 Wednesday, 19.09.2018		View the presentations you missed during Congress! More than 1,700 webcasts and slide presentations, 1,600 e-posters and 4,200 abstracts from the International Congress in Paris and are now available.

Citations should be made in the following way: Authors. Title. Eur Respir J 2018; 52: Suppl. 62, abstract number.

Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations

Thematic Poster
Chairs: S. Belo Ravara (Covilhã, Portugal), J. Allinson (London, United Kingdom), K. Lewis (Llanelli (Dyfed), United Kingdom), A. Diamanti (Pefki, Greece)

Download all media

Active and passive smoking during pregnancy A. Diamanti (Athens, Greece), V. Raftopoulos (Limassol, Cyprus), K. Lykeridou (Athens, Greece), A. Daliani (Athens, Greece), S. Giannareli (Athens, Greece), S. Palaiou (Athens, Greece), S. Schoretsaniti (Athens, Greece), E. Zervas (Patras, Greece), C. Gratziou (Athens, Greece), P. Katsaounou (Athens, Greece)
Effect of a short tobacco cessation intervention among pregnant women: pilot results of the TOB-G project T. Peleki (Athens, Greece), V. Vivilaki (Athens, Greece), V. Vyzikidou (Athens, Greece), S. Papadakis (ottawaAthens, Canada), A. Loukopoulou (Athens, Greece), V. Evangelopoulou (Athens, Greece), C. Vardavas (Athens, Greece), P. Behrakis (Athens, Greece)
smoking cessation program: where do our patients come from? A. Santos (Lisboa, Portugal), I. Oliveira (Lisboa, Portugal), J. Carvalho (Lisboa, Portugal), R. Campanha (Lisboa, Portugal), C. Guimarães (Lisboa, Portugal), M. Fradinho (Lisboa, Portugal), C. Matos (Lisboa, Portugal), F. Nogueira (Lisboa, Portugal)
Characteristics of the patient who is successful or not in stopping smoking R. Godoy Mayoral (Albacete, Spain), F. Callejas González (Albacete, Spain), A. Tornero Molina (Albacete, Spain), M. Genovés Crespo (Albacete, Spain), R. Sánchez Simón Talero (Albacete, Spain), P. Lopez Miguel (Albacete, Spain), P. Tarraga Lopez (Albacete, Spain)
Treatment adherence and short term outcomes of smoking cessation outpatient clinic patients D. Karadogan (Rize, Turkey), ö. öNal (Burdur, Turkey), D. Say sAhin (Burdur, Turkey), Y. Kanbay (Rize, Turkey), S. Alp (Rize, Turkey), ü. sAhin (Rize, Turkey)
Adherence to a blended smoking cessation treatment L. Siemer (Enschede, Netherlands), M. Brusse-Keizer (Enschede, Netherlands), M. Postel (Enschede, Netherlands), S. Ben Allouch (Enschede, Netherlands), A. Patrinopoulos (Enschede, Netherlands), R. Sanderman (Enschede; Groningen, Netherlands), M. Pieterse (Enschede, Netherlands)
How does reimbursement status affect the smoking cessation interventions? D. Karadogan (Rize, Turkey), Ö. Önal (Burdur, Turkey), Y. Kanbay (Artvin, Turkey)
Supporting recruitment of community pharmacies for the STOP trial training using an embedded recruitment model (Russian doll approach) W. James (London, United Kingdom), S. Jumbe (London, United Kingdom), . Madurasinghe (London, United Kingdom), S. Eldridge (London, United Kingdom), S. Taylor (London, United Kingdom), C. Houlihan (London, United Kingdom), C. Griffiths (London, United Kingdom), R. Walton (London, United Kingdom)
Smoking and severe persistent asthma P. Katsaounou (Athens, Greece), M. Odemyr (Brussels, Belgium), O. Spranger (Vienna, Austria), A. Lindberg (Umeå, Sweden), M. Hyland (Devon, United Kingdom), ?. Gasser (Basel, Switzerland), M. Larbig (Basel, Switzerland), I. Kottakis (Basel, Switzerland), X. Jaumont (Basel, Switzerland), I. Kasujee (Basel, Switzerland)
Analysis of the ratio of ACO in elderly and non-elderly asthmatics with a history of smoking A. Ebihara (Tokyo, Japan), A. Nagai (Tokyo, Japan), T. Iwamoto (Tokyo, Japan), I. Kuwahira (Tokyo, Japan)
Smoking cessation among COPD and asthma patients: burden vs. motivation T. Kovacevic (Sremska Kamenica, Republic of Serbia), B. Zaric (Sremska Kamenica, Republic of Serbia), D. Bokan (Sremska Kamenica, Republic of Serbia), M. Jovancevic Drvenica (Sremska Kamenica, Republic of Serbia), S. Hromiš (Sremska Kamenica, Republic of Serbia), B. Zvezdin (Sremska Kamenica, Republic of Serbia), I. Andrijevic (Sremska Kamenica, Republic of Serbia), I. Kopitovic (Sremska Kamenica, Republic of Serbia), B. Perin (Sremska Kamenica, Republic of Serbia), P. Bamidis (Thessaloniki, Greece)
Does chronic obstructive pulmonary disease (COPD) impact on women smoking cessation approach? H. Rejeb (sousse, Tunisia), M. Ben Khelifa (sousse, Tunisia), R. Kaddoussi (sousse, Tunisia), S. Jdidi (sousse, Tunisia), H. Ben Salem (Sousse, Tunisia), W. Benzarti (sousse, Tunisia), S. Aissa (sousse, Tunisia), I. Gargouri (sousse, Tunisia), A. Abdelghani (sousse, Tunisia), A. Garrouche (sousse, Tunisia), A. Hayouni (sousse, Tunisia), M. Benzarti (sousse, Tunisia)
“Lung age” – a motivational smoking cessation tool in smokers with chronic obstructive pulmonary disease I. Buculei Porosnicu (Iasi, Romania), L. Trofor (Iasi, Romania), C. Vicol (Iasi, Romania), I. Grosu (Iasi, Romania), A. Tifrea (Iasi, Romania), C. Vardavas (Athens, Greece), P. Behrakis (Athens, Greece), A. Trofor ( Iasi, Romania)
The effect of bupropion on smoking cessation and sleep physiology in COPD and asthma patients D. Bokan (Sremska Kamenica, Republic of Serbia), M. Jovancevic Drvenica (Sremska Kamenica, Republic of Serbia), T. Kovacevic (Sremska Kamenica, Republic of Serbia), B. Zaric (Sremska Kamenica, Republic of Serbia), S. Hromis (Sremska Kamenica, Republic of Serbia), B. Zvezdin (Sremska Kamenica, Republic of Serbia), I. Kopitovic (Sremska Kamenica, Republic of Serbia), I. Andrijevic (Sremska Kamenica, Republic of Serbia), B. Perin (Sremska Kamenica, Republic of Serbia), P. Bamidis (Thessaloniki, Greece)
An Evaluation of a Smoking Cessation Service in a Regional Cardio-Thoracic Centre. D. Beach (Harefield, United Kingdom), T. Jolliffe (Harefield, United Kingdom), C. Chalwin (Harefield, United Kingdom), J. Morjaria (Harefield, United Kingdom)
The impact of tobacco cessation on the evolution of patients with non-ST-elevation acute coronary syndromes. N. Ayedi (Sfax, Tunisia), R. khemakhem (Sfax, Tunisia), N. Kammoun (Sfax, Tunisia), W. Feki (Sfax, Tunisia), N. Bahloul (Sfax, Tunisia), N. Moussa (Sfax, Tunisia), I. Yangui (Sfax, Tunisia), H. Ayedi (Sfax, Tunisia), S. Kammoun (Sfax, Tunisia), R. Hammami (Sfax, Tunisia), S. Kammoun (Sfax, Tunisia)
Smoking in individuals with HIV/AIDS: a qualitative-quantitative approach I. de Godoy (Botucatu, Brazil), L. Lopes Devóglio (Botucatu, Brazil), I. Godoy (Botucatu, Brazil)
Does depression disorder have an important impact in smoking cessation? A. Rodrigues Vieira (Lisboa, Portugal), J. Ferra (Lisboa, Portugal), C. Matos (Lisboa, Portugal), F. Nogueira (Lisboa, Portugal)
HTR2A genetic variants as risk factors for cigarette smoking at an early age and relapse to smoking cessation treatment. G. Pérez-Rubio (Mexico, Mexico), L. López-Flores (Mexico, Mexico), S. García-Carmona (Mexico, Mexico), L. García-Gómez (Mexico, Mexico), V. Noé-Díaz (Mexico, Mexico), E. Ambrocio-Ortiz (Mexico, Mexico), K. Nava-Quiroz (Mexico, Mexico), F. Morales-González (Mexico, Mexico), A. Del Angel-Pablo (Mexico, Mexico), A. Ramírez-Venegas (Mexico, Mexico), R. Falfán-Valencia (Mexico, Mexico)